Related Experiment Videos
Definition of the interferon-alpha receptor-binding domain on the TYK2 kinase
1Department of Pathology and the Irving Comprehensive Cancer Center, Columbia University, College of Physicians and Surgeons, New York, New York 10032, USA.
Abstract:
Interferons and cytokines modulate gene expression via a simple, direct signaling pathway containing receptors, JAK tyrosine kinases, and STAT transcription factors. The interferon-alpha pathway is a model for these cascades. Two receptors, IFNaR1 and IFNaR2, associate exclusively in a constitutive manner with two JAK proteins, TYK2 and JAK1, respectively. Defining the molecular interface between JAK proteins and their receptors is critical to understanding the signaling pathway and may contribute to the development of novel therapeutics. This report defines the IFNaR1 interaction domain on TYK2. In vitro binding studies demonstrate that the amino-terminal half of TYK2, which is approximately 600 amino acids long and contains JAK homology (JH) domains 3-7, comprises the maximal binding domain for IFNaR1. A fragment containing amino acids 171-601 (JH3-6) also binds IFNaR1, but with reduced affinity. Glutathione S-transferase-TYK2 fusion proteins approximating either the JH6 or JH3 domain affinity-precipitate IFNaR1, suggesting that these are major sites of interaction within the larger binding domain. TYK2 amino acids 1-601 act in a dominant manner to inhibit the transcription of an interferon-alpha-dependent reporter gene, presumably by displacing endogenous TYK2 from the receptor. This same fragment inhibits interferon-alpha-dependent tyrosine phosphorylation of TYK2, STAT1, and STAT2.
Insights
Researchers identified the specific region on TYK2 (tyrosine kinase 2) that binds to the IFNaR1 receptor. This discovery is crucial for understanding interferon signaling and developing new therapies.
Area of Science:
- Immunology
- Molecular Biology
- Signal Transduction
Background:
- Interferons and cytokines regulate gene expression through JAK-STAT pathways.
- The interferon-alpha (IFN-α) pathway, involving receptors IFNaR1/IFNaR2 and JAK kinases (TYK2/JAK1), serves as a model system.
- Understanding the molecular interactions within this pathway is key for therapeutic development.
Purpose of the Study:
- To define the specific molecular interface on TYK2 responsible for binding to the IFNaR1 receptor.
- To elucidate the functional consequences of this interaction in the context of IFN-α signaling.
Main Methods:
- In vitro binding assays using glutathione S-transferase-TYK2 fusion proteins.
- Analysis of binding affinity using varying lengths of TYK2 fragments.
- Reporter gene assays to assess transcriptional inhibition.
- Western blotting to evaluate tyrosine phosphorylation of signaling proteins.
Main Results:
- The amino-terminal half of TYK2 (approx. 600 amino acids, JH3-7 domains) constitutes the maximal binding domain for IFNaR1.
- Specific domains, JH6 and JH3, were identified as major interaction sites with IFNaR1.
- A TYK2 fragment (amino acids 1-601) inhibited IFN-α-dependent gene transcription and phosphorylation of TYK2, STAT1, and STAT2.
Conclusions:
- The N-terminal region of TYK2, particularly JH3 and JH6 domains, is critical for IFNaR1 binding.
- This interaction is essential for mediating IFN-α-induced signaling.
- Targeting this interface may offer a strategy for modulating IFN-α responses.